Resumen
A pesar de que la información disponible en la literatura sobre la embarazada con epilepsia ha proliferado en los últimos años, aún hay mucho por hacer.
El propósito de este artículo es revisar la literatura y describir consideraciones prácticas sobre el enfoque y manejo de la embarazada con epilepsia.
El tratamiento de la mujer embarazada con epilepsia constituye un importante reto clínico. El tratamiento por un equipo interdisciplinario entre obstetras, ginecólogos, neurólogos y en su momento, neonatólogos, es una condición fundamental para disminuir el riesgo que presentan las pacientes, pues muchos problemas pueden prevenirse.
El embarazo debe ser planeado en lo posible para recibir la consejería pertinente. Esto con el fin de formular suplementos de ácido fólico, mantener la adherencia al tratamiento anticonvulsivante, aclarar los riesgos de teratogenicidad así como la importancia del cuidado preconcepcional, antepartum y postpartum. El ajuste de dosis de anticonvulsivante debe basarse en aspectos clínicos y no en niveles séricos.
Muchos grupos han sugerido guías de manejo clínico para estas pacientes. A pesar de que el futuro es prometedor en esta área, aún persisten algunas preguntas y el interés por progresar en este campo
Citas
Madden V. Women with epilepsy are not getting pregnancy advice. BMJ 1999 May 22; 318: 1374.
Morrell MJ. Epilepsy in women: the science of why it is special. Neurology 1999; 53: S42 - S48.
Oxman AD, Sackett DL, Guyatt GH. User’s guides to the medical literature. How to use an overview. Evidence based medicine working group. JAMA 1994; 272: 1367.
Pack AM, Morrell MJ. Treatment of women with epilepsy. Semin Neurol 2002; 22: 289-297.
Kaneko S. Pregnancy and quality of life in women with epilepsy. Clinical Therapeutics 1998: 20: 30 - 47.
O’Brien TJ, Vajda FJ. Maternal-fetal medicine. Contemporary management of epilepsy in pregnancy. Aust N Z J Obstet Gynaecol 2000; 40: 413-415.
Cascino GD. Epilepsy: contemporary perspectives on evaluation and treatment. Mayo Clin Proc 1994; 69: 199-211.
Crawford P. Epilepsy and Pregnancy Seizure 1993; 2: 87-90.
Pennell PB. Pregnancy in the women with epilepsy: maternal and fetal outcomes. Semin Neurol 2002; 22: 299-307.
Kaaja E, Kaaja R, Matila R, Hilesmaa V. Enzyme- inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002; 58: 549-553.
Cleland PG. Management of pre-existing disorders in pregnancy: epilepsy. Prescr J 1996; 36: 102-109.
Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42(suppl 5): 149-160.
Dean JCS, Moore SJ, Turnpenny PD. Developing diagnostic criteria for the fetal anticonvulsant syndromes. Seizure 2000; 9: 233-234.
Lewis DP, Van Dyke DC, Stumbo PJ, Berg MJ. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: antiepileptic drugs, contraceptives, smoking and folate. Ann Pharmacother 1998; 32: 802-817.
Buehler BA, Delmont D, van Waes M, Finnel RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990; 322: 1567-1572.
Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland T. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Intl J Epidemiol 1978; 7: 241-247.
Annegers JF, Elveback LR, Hauser WA, Kurland LT. Do anticonvulsants have a teratogenic effect? Arch Neurol 1974; 31: 364-373.
Annegers JF, Baumgartner KB, Hauser Wa, Kurland LT. Epilepsy, antiepiltic drugs, and the risk of spontaneous abortion. Epilepsia 1988; 29: 451-458.
Bernus I, Hooper WD, Dickinson RG, Eadie MJ. Effects of pregnancy on various pathways of human antiepileptic drug metabolism. Clinical Neuropharmacology 1997; 20: 13-21.
Gilmore J, Pennell PB, Stern BJ. Medication use during pregnancy for neurologic conditions. Neurol Clin North Am 1998; 16: 189-206.
Betts T, Fox C. Proactive pre-conception coun-selling for women with epilepsy: is it effective? Seizure 1999; 8: 322-327.
Guidelines for the care of epileptic women of childbearing age. Epilepsia 1989; 30: 409-410.
Brodie MJ. Epilepsy, anticonvulsants and pregnancy. In Rose, Chadwikc SD, Crawford R, eds. New York: John Wiley & Sons Ltd. 1987: 81-92.
Chadwick D. The discontinuation of AED therapy. In Pedley TA, Meldrum BS eds: Recent advances in Epilepsy. Edinburgh: Churchill Livingstone. 1985: 111-124.
Waters CH, Belai Y, Gott PS, Shen P, De Giorgio CM. Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 1994; 51: 250-253.
Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26: 631-635.
Dansky LV, Rosenblatt DS, Anderman E. Mechanisms of teratogenesis: Folic acid and antiepileptic therapy. Neurology 1992; 42(suppl 5): 32-42.
Kuruvilla A. Factors influencing reactions to anticonvulsant drugs. Adverse Drug React Toxicol Rev 1993; 12: 233-252.
Pennel PB. The importance of monotherapy in pregnancy. Neurology 2003; 60(Suppl 4): S31-S38.
Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW, et al. The risk of spina bifida aperta after first trimeter valproate exposure in a prenatal cohort. Neurology 1992; 42(suppl 5): 119-125.
Donaldson JO. The pregnant epileptic: fetal risks from anticonvulsant therapy. JAMA 1990; 264: 1990.
El-Sayed YY. Obstetric and Gynecologic Care of Women with Epilepsy. Epilepsia 1998; 39: S17-S25.
Eadie MJ. The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy. Clin Pharmacokinet 1995; 29: 29-35.
Eller DP. Patterson CA., Webb GW. Maternal and fetal implications of anticonvulsive therapy during pregnancy. Obstetrics and gynecology clinic of North America 1997; 24: 523 - 525.
Gaily E, Granstrom ML, Hillesmaa V. Minor anomalies in offspring of epileptic mothers. J Pediatr 1988; 112: 520-529.
Gaily E. Kantola-Sorsae E. Granstrom M-L. Intelligence of children of epileptic mothers. J Pediatr 1988; 113: 677-684.
Gaily EK, Granstrom M-L, Hiilesmaa VK, Bardy AH. Head circumference in children of epileptic mothers: Contributions of drug exposure and genetic background. Epilepsy 1990; 5: 217-222.
Nadel AS, Green JK, Holmes LB, Frigoletto FD, Benacerrat BR. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. N Engl J Med 1990; 323: 557-561.
American Academy of Neurology. Quality Standards subcomité. Practice parameter: management issues for women with epilpsy (summary statement) Neurology 1998; 51: 944-948.
Brons JT, van der Harten HJ, van Geijn HP, Wladimiroff JW, Niermeijer MF, Lindhout D, Stuart PA, Meijer CJ, Arts NF. Prenatal ultrasonographic diagnosis of radial-ray reduction malformations. Prenat Diagn 1990; 10: 279-288.
Holmes LB. Prevention of neural tube defects. J Pediatr 1992; 120: 918-919.
Van den Hof MC, Nicolaides KH, Campbell J, Campbell S. Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 1990; 162: 322-327.
Simpson LL, Marx GR, Dalton ME. The detection of congenital heart disease in a tertiary care ultrasound practice. Am J Ostet Gynecol 1995; 172: 354.
Swartjes JM, Van Geijn HP. Pregnancy and Epilepsy. Eur J Obstet Gynecol Reprod Biol 1998; 79: 3-11.
Sirinivasan G, Seeler RA, Tiruvury A. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol 1982; 59: 250-252.
Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Vogels-Mentink G, Motohara K, De Abreu R, Monnens L. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol 1993; 168: 923-927.
Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Motohara K, Monnens L. Supplementation for vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiecy. Am J Obstet Gynecol 1993; 168: 884-888.
Drugs and Therapeutics Bulletin: Epilepsy and Pregnancy. 1994; 32: 49-51.
Howe AM., Oakes DJ., Woodman PD., Webster WS. Prothrombin and PIVKA II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia 1999; 40: 980-984.
Koch S, Jager-Roman E, Losche G, Nau H, Rating D, Helge H. Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta Pediatrica 1996; 6: 739-746.
Loretto-Pleet J. Excreción de fármacos en leche humana. Pediatrics and Nutrition Review, Excerpta Medica 1987: 1-10.
Froescher W, Eichelbaum M, Niesen M, Dietrich K, Rausch P. Carbamazepine levels in breast milk. Therapeutic Drug Monitoring 1984; 6: 266-271.
Ornoy A, Moerman L, Lukashova I, Arnon J. The outcome of children exposed in utero to benzodiazepines. Teratology 1997; 55: 102.
Yerby MS. Contraception, pregnancy and lactation in women with epilepsy. Baillieres Clin Neurol 1996; 5: 887-908.
Malone FD, D’Álton ME. Drugs in Pregnancy: anticonvulsants. Semin Perinatol 1997; 21: 114-123.
Krauss GL, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology 1996; 46: 1534-1539.
Commission on Genetics, pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of epileptic women of childbearing age. Epilepsia 1989; 30: 409-410.
Commission on Genetics, pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of epileptic women of childbearing age. Epilepsia 1993; 34: 588-589.
Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists: ACOG educational bulletin. Seizure disorders in pregnancy. Int J Gynaecol Obstet 1997; 56: 279-286.
Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: management issues for women with epilepsy. Neurology 1998; 51: 944-948.
Crawford P. Appleton R, Betts T, et al. The women with epilepsy Guidelines Development Group: best practice guidelines for the management of women with epilepsy. Seizure 1999; 8: 201-217.
SIGN. Diagnosis and management of epilepsy in adults: a national clinical guideline recommended for use in Scotland. Disponible en http://www.sign.ac.uk. Fecha de último acceso 26 de octubre de 2004.
NHS. Newer drug for epilepsy in adults. Disponible en http://www.nice.org.uk/pdf/TA076fullguidance.pdf Fecha de último acceso 26 de octubre de 2004.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.